WashU Medicine researchers found that dozens of blood proteins shifted during treatment with the anti-amyloid medication lecanemab, which could enable future blood tests monitoring a person’s response to the drug. The post Blood proteins reveal effects of Alzheimer’s drug appeared first on The Source .